TITLE

Breast cancer leptomeningeal metastasis: propensity of breast cancer subtypes for leptomeninges and the analysis of factors influencing survival

AUTHOR(S)
Niwińska, Anna; Rudnicka, Halina; Murawska, Magdalena
PUB. DATE
March 2013
SOURCE
Medical Oncology;Mar2013, Vol. 30 Issue 1, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The aim of the study was to define biological subtypes of breast cancer that have the propensity to metastasize to the leptomeninges and to assess factors influencing survival from detection of leptomeningeal metastatis (LM). One hundred and eighteen consecutive breast cancer patients with LM were treated in one institution, between the years 1999 and 2009; 40.5 % of patients had triple-negative subtype, 37.5 % had luminal A subtype and 22 % had HER2-positive subtypes (luminal B and HER2). Of patients with LM, 35 % had lobular cancer. Median survival from the detection of LM was 18 weeks, and 1-year survival was 16 %. Cox multivariate analysis revealed that performance status and systemic treatment statistically significantly influenced survival of patients with LM. Triple-negative biological subtype and lobular histological type of breast cancer had the propensity to metastasize to the leptomeninges. Performance status and systemic treatment ordered after detection of LM statistically significantly influenced survival.
ACCESSION #
85859765

 

Related Articles

  • CSF CA 15-3 in breast cancer-related leptomeningeal metastases. Le Rhun, Emilie; Kramar, Andrew; Salingue, Sophie; Girot, Marie; Rodrigues, Isabelle; Mailliez, Audrey; Zairi, Fahed; Bakhache, Edgar; Robin, Yves; Taillibert, Sophie; Dubois, François; Bonneterre, Jacques; Chamberlain, Marc // Journal of Neuro-Oncology;Mar2014, Vol. 117 Issue 1, p117 

    The sensitivity of CSF cytology, the standard method for diagnosis of leptomeningeal metastases (LM), is low. Serum cancer antigen 15-3 (CA 15-3) is frequently used for the monitoring of patients with breast cancer (BC) and is a laboratory test available in most centers. The aim of the current...

  • Predicting Sentinel Lymph Node Metastases in Infiltrating Breast Carcinoma With Vascular Invasion. Jonjić, Nives; Mustać, Elvira; Dekanić, Andrea; Marijić, Blažen; Gašpar, Božena; Kolić, Ivana; Čoklo, Miran; Sasso, Franco // International Journal of Surgical Pathology;Oct2006, Vol. 14 Issue 4, p306 

    Sentinel lymph node and clinically negative axillary node status was compared with well-known clinicopathological characteristics such as tumor size, histologic and nuclear grade, lymphovascular invasion, steroid receptor, and HER-2 status in patients with breast cancer (pT1 and pT2). Positive...

  • Endobronchial Metastasis from Breast Carcinoma. Pyreddy, Lovdru // Internet Journal of Pulmonary Medicine;2005, Vol. 5 Issue 1, p40 

    Breast cancer is a common malignancy. Lung metastasis to the parenchyma can be seen in 20 to 50% of series. Endobronchial metastasis due to breast carcinoma is a rare finding in these patients and entitles a grim prognosis. Majority of patients have minimal or no pulmonary symptoms. We report a...

  • Meningeal carcinomatosis preceded by a rapid increase in serum CA19-9 levels in a patient with breast cancer. Yasumoto, Kazuo; Takahashi, Yutaka; Mai, Masayoshi; Kawashima, Atsuhiro // International Journal of Clinical Oncology;Aug2005, Vol. 10 Issue 4, p276 

    We report a patient with breast cancer who developed meningeal carcinomatosis that was preceded by a rapid increase in the serum level of carbohydrate antigen (CA) 19-9. A 60-year-old woman was admitted for primary breast cancer with multiple metastases to the vertebrae. She received...

  • 5-Year Follow-up After Sentinel Node Mapping for Breast Cancer Demonstrates Better Than Expected Treatment Outcomes. Fuhrman, George M.; Gambino, Jamie; Bolton, John S.; Farr, Gist; Xiaozhang Jiang // American Surgeon;Jul2005, Vol. 71 Issue 7, p564 

    We conducted this study to provide one of the initial assessments of treatment outcomes for breast cancer patients evaluated with sentinel node mapping. All patients diagnosed with breast carcinoma, evaluated with sentinel node mapping, and followed for 5 years were divided into three groups...

  • Male Breast Cancer: 10-Year Experience at Mansoura University Hospital in Egypt. El-Beshbeshi, Wafaa; Abo-Elnaga, Engy M. // Cancer Biology & Medicine;2012, Vol. 9 Issue 1, p23 

    Objective Male breast cancer (MBC) is a rare disease representing less than 1% of all malignancies. The objective of the study is to report clinicopathological characteristics, treatment patterns, and outcomes of MBC in Mansoura University Hospital, Egypt. Methods This retrospective study...

  • Cancer Transcriptomics: Modeling metastasis. Ramaswamy, Sridhar // European Journal of Human Genetics;Jan2006, Vol. 14 Issue 1, p1 

    The article comments on the use of microarrays in the identification of genes that may play a role in mediating breast cancer metastasis to the lung. The molecular basis of metastasis is poorly understood due to the complexity of the metastatic phenotype. The use of whole-tumor molecular...

  • Quantification of receptor-ligand binding with [F]fluciclatide in metastatic breast cancer patients. Tomasi, Giampaolo; Kenny, Laura; Mauri, Francesco; Turkheimer, Federico; Aboagye, Eric // European Journal of Nuclear Medicine & Molecular Imaging;Dec2011, Vol. 38 Issue 12, p2186 

    Purpose: The purpose of the study was to estimate the receptor-ligand binding of an arginine-glycine-aspartic acid (RGD) peptide in somatic tumours. To this aim, we employed dynamic positron emission tomography (PET) data obtained from breast cancer patients with metastases, studied with the...

  • Neoplastic Disease: Part 2. Pelino, Carlo J.; Pizzimenti, Joseph J. // Review of Optometry;11/15/2010, Vol. 147 Issue 11, p125 

    The article focuses on the role of optometrists to their patients with breast cancer. It mentions the responsibility of every optometrist in determining the visual condition of their patients with the mentioned cancer, particularly in checking the possibility of intraocular/orbital metastasis....

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics